United States
Chief Science Officer with 25+ years of experience leading scientific, clinical, regulatory, and quality programs across the full medical device product lifecycle. Brings deep expertise in defining scientific and clinical research strategies to align technology development with regulatory pathways and drive adoption across multiple technologies and diverse therapeutic areas. Provides strategic leadership and hands-on execution of clinical programs spanning early feasibility studies, pre-market regulatory trials, post-market evidence generation, and medical engagement initiatives that strengthen value propositions for key stakeholders. Proven ability to build and lead high-performing, cross-functional teams to deliver results under aggressive timelines and advance corporate objectives. Leads with integrity, authenticity, and empathy, and believes the strongest innovations emerge at the intersection of scientific rigor, collaborative leadership, and a growth mindset. Deeply committed to developing talent, building trusted partnerships, and advancing healthcare through evidence-driven, patient-centered innovation.
- Defined scientific and clinical strategy for a dermatology device platform, guiding products from early development through global commercialization. - Built and led Clinical Affairs, Clinical Education, R&D, Regulatory Affairs, and Quality teams. - Designed and oversaw first-in-human, pivotal, and post-market clinical programs supporting FDA clearances, indication expansion, and market adoption. - Led regulatory strategy and submissions across North America, EU/UK, LATAM, APAC, and the Middle East. - Managed R&D through development and launch of first commercial products in North America and China
- Created clinical and regulatory plan for early-stage company developing endoscopically guided neuromodulation device - Designed and executed pivotal clinical study leading to FDA clearance for treatment of chronic rhinitis
- Member of executive leadership team that launched novel non-invasive body contouring device - Defined and executed clinical research programs to optimize treatment protocols, expand product indications, strengthen clinical evidence, and drive customer adoption - Established and executed global regulatory strategies, overseeing submissions that enabled international market expansion - Led advanced technologies engineering group to deliver product innovations to fuel portfolio growth
- Directed preclinical and clinical evaluation of neuroablation device for interventional pain management - Developed clinical trial strategies to support commercialization; built and led clinical affairs team - Established on site clinic to facilitate execution of clinical studies and procedure optimization
- Provided research leadership for development of pulmonary vein isolation catheter for treatment of atrial fibrillation